UC PRO.AKT.ANL. 08/24 PAH3/ DE000HC6UHX0 /
21/06/2024 21:45:40 | Var.-0.270 | Denaro21:59:49 | Lettera21:59:49 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
99.340EUR | -0.27% | - Quantità in denaro: 35,000 |
- Quantità in lettera: 35,000 |
PORSCHE AUTOM.HLDG V... | 40.00 - | 23/08/2024 | Call |
Newsfile Corp
03:51
Cydcor Secures DIRECTV Dealer of Year Revolution Award for an Unprecedented Eighth Consecutive Year
GlobeNewswire
03:22
Xaman Wallet Integrates C14 for Seamless Fiat On-Ramp, Simplifying XAH and XRP Purchases
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mal...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Uni...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Har...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enp...
GlobeNewswire
03:00
RIVIAN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire
03:00
EXSCIENTIA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit...
GlobeNewswire
03:00
AUTODESK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit H...
GlobeNewswire
02:00
B2Gold Announces Voting Results from its 2024 Annual General and Special Meeting
GlobeNewswire
01:15
Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2024 Results on June 28, 2024
GlobeNewswire
01:10
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders
GlobeNewswire
00:45
Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wi...
GlobeNewswire
00:38
Toyota Announcement: If You Have Suffered Losses in Toyota Motor Corporation (NYSE: TM), You Are Enc...
GlobeNewswire
00:30
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-...